Monocytes, Macrophages, and Metabolic Disease in Atherosclerosis
Atherosclerotic cardiovascular disease (CVD) is a lipid-driven chronic inflammatory disease, in which macrophages are responsible for taking up these lipids and driving disease progression. Over the years, we and others have uncovered key pathways that regulate macrophage number/function and identif...
Main Authors: | Michelle C. Flynn, Gerard Pernes, Man Kit Sam Lee, Prabhakara R. Nagareddy, Andrew J. Murphy |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-06-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphar.2019.00666/full |
Similar Items
-
Innate immunity and monocyte-macrophage activation in atherosclerosis
by: Davies Alun H, et al.
Published: (2011-04-01) -
Loss of Rictor in Monocyte/Macrophages Suppresses Their Proliferation and Viability Reducing Atherosclerosis in LDLR Null Mice
by: Vladimir R. Babaev, et al.
Published: (2018-02-01) -
Voltage-gated sodium channel inhibitor reduces atherosclerosis by modulating monocyte/macrophage subsets and suppressing macrophage proliferation
by: Haiying Sun, et al.
Published: (2019-12-01) -
Monocyte Recruitment, Specification, and Function in Atherosclerosis
by: Ki-Wook Kim, et al.
Published: (2021-12-01) -
Cholesterol efflux pathways regulate myelopoiesis: A potential link to altered macrophage function in atherosclerosis
by: Andrew James Murphy, et al.
Published: (2014-10-01)